Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1113 participants
OBSERVATIONAL
2017-12-15
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery
NCT05922982
Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.
NCT02479529
Evaluation of the HPA Axis in Patients With Vasoplegic Syndrome After Cardiac Surgery
NCT06371976
In Situ Exploration of Vascular Function in Vasoplegic Shock Following Cardiac Surgery With Cardiopulmonary Bypass
NCT06318689
Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.
NCT04812717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients covered by a social insurance system.
* Patients who have given oral consent to participate after full information
Exclusion Criteria
* Preoperative ECMO / ECLS.
* Cardiac assistance.
* Minor,
* Patient deprived of liberty, or under safeguard of justice.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Michel MERTES, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU STRASBOURG
Jean-Luc Simon Jean-Baptiste FELLAHI, Professor
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
FISCHER Marc Olivier, Professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Caen
GIRARD Claude, Professor
Role: PRINCIPAL_INVESTIGATOR
CHU DIJON
Longrois Dan, Doctor
Role: PRINCIPAL_INVESTIGATOR
APHP, Paris
BESNIE Emmanuel, Doctor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2017_843_0014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.